04.28.20

Clearside Biomedical Revises NDA Resubmission Timeline and Xipere Commercial Partnership with Bausch Health

Source: Clearside Biomedical

03.25.20

Bausch Health Donates Health Care Products And Supplies In Response To COVID-19 Pandemic

Source: Bausch Health

01.28.20

Bausch Health and Clearside Biomedical Announce Publication of Pivotal Phase 3 Data on Xipere

Source: Bausch Health

12.20.19

Bausch Health Licenses Novaliq’s NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction

Source: Bausch Health

10.23.19

Bausch Health Licenses Clearside Biomedical’s Xipere, An Investigational Treatment For Macular Edema Associated With Uveitis

Source: Bausch Health

08.08.19

Bausch Health CEO: Big Pharma Will Survive US Drug Regulations

Source: CNBC

12.13.18

Bausch Health to Purchase Majority of Synergy Pharmaceuticals’ Assets, Including Trulance

Source: FirstWord

11.07.18

Bausch’s Papa Says ‘Transformation on Track’ as Debt Paydown Continues

Source: Financial Post

View more stories